Jessica Ritsick will lead the March 24 pre-conference session “Medical Devices, Combination Products, and Companion Diagnostics: The 2026 Playbook” at this event hosted by the American Conference Institute.
As LDT obligations phase in and AI and ML devices rely on PCCPs for post-market change, seams between drug, diagnostic, and software can create late surprises. This workshop converts those moving parts into calendars, change-control plans, evidence strategies, and label dependencies that keep teams aligned and timelines intact.
For more information, click here.